This may be due to T cell exhaustion induced by vaccination by upregulating checkpoint molecules, such as PD-1, or neoantigen editing that allow cancer cells to adapt to the driver mutations such as KRAS G12 mutations13. This evidence concerns the gene KRAS and cancer.